CCS
CARBOXYMETHYLATED CYSTEINE
Find entries where:
Chemical Component Summary | |
|---|---|
| Name | CARBOXYMETHYLATED CYSTEINE |
| Identifiers | (2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid |
| Formula | C5 H9 N O4 S |
| Molecular Weight | 179.19 |
| Type | L-PEPTIDE LINKING |
| Isomeric SMILES | N[C@@H](CSCC(O)=O)C(O)=O |
| InChI | InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 |
| InChIKey | GBFLZEXEOZUWRN-VKHMYHEASA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 20 |
| Chiral Atom Count | 1 |
| Bond Count | 19 |
| Aromatic Bond Count | 0 |
Drug Info: DrugBank
| DrugBank ID | DB04339 |
|---|---|
| Name | Carbocisteine |
| Groups |
|
| Description | Carbocisteine is a mucolytic that reduces the viscosity of sputum to relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis through easier expulsion of mucus. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions as they are functional antagonists. Carbocisteine is produced by alkylation of cysteine with chloroacetic acid. |
| Synonyms |
|
| Indication | Used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis. |
| Categories |
|
| ATC-Code | R05CB03 |
| CAS number | 638-23-3 |
Drug Targets
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Glutathione S-transferase P | MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLY... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
